AIM ImmunoTech(DE:HXB)
€6.090.00 (0.00%)
DE:HXB
AIM ImmunoTech ownership
€6.09
At close:0.00 (0.00%)
AIM ImmunoTech (HXB) Ownership - Who Owns AIM ImmunoTech?
1 Followers
AIM ImmunoTech (HXB) Ownership Overview
- 0.81% Insiders
- 0.13% Mutual Funds
- <0.01% Other Institutional Investors
- 99.07% Public Companies and Individual Investors
The ownership structure of AIM ImmunoTech (DE:HXB) stock is a mix of institutional, retail, and individual investors. Approximately 0.13% of the company’s stock is owned by Institutional Investors, 0.81% is owned by Insiders, and 99.07% is owned by Public Companies and Individual Investors.
The ownership structure of AIM ImmunoTech (DE:HXB) stock is a mix of institutional, retail, and individual investors. Approximately 0.13% of the company’s stock is owned by Institutional Investors, 0.81% is owned by Insiders, and 99.07% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Nov 12, 2026 | Thomas Equels | $4,900 | |
| Nov 11, 2026 | Thomas Equels | $5,070 | |
| Nov 09, 2026 | Thomas Equels | $5,008 | |
| Nov 08, 2026 | Thomas Equels | $1,913 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Thomas Equels | 293,095 | Insider | 0.73% | 1,975,460 |
| Fidelity Concord Street Trust | 44,766 | Institution | 0.11% | 301,723 |
| David Chemerow | 28,441 | Insider | 0.07% | 191,692 |
| Victory Portfolios Iii | 5,279 | Institution | 0.01% | 35,580 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Concord Street Trust | 44,766 | Institution | 0.11% | 301,723 |
| Victory Portfolios Iii | 5,279 | Institution | 0.01% | 35,580 |
FAQ
Who Owns AIM ImmunoTech (DE:HXB)?
According to the latest TipRanks data, approximately 0.13% of the company's stock is held by institutional investors, 0.81% is held by insiders, and 99.07% is held by public companies and individual investors.
What percentage of AIM ImmunoTech (DE:HXB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.13% of AIM ImmunoTech (DE:HXB) stock is held by institutional investors: 0.13% by mutual funds and <0.01% by other institutional investors.
What percentage of AIM ImmunoTech (DE:HXB) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.07% of AIM ImmunoTech (DE:HXB) stock is held by public companies and individual investors.
Who owns the most shares of AIM ImmunoTech (DE:HXB)?
Thomas Equels owns the most shares of AIM ImmunoTech (DE:HXB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
